Allergan, Richter prep for FDA OK with positive PhIII for cariprazine in bipolar depression
Allergan $AGN and its partner Gedeon Richter came out this morning with some affirming Phase III data of its drug cariprazine, setting the duo on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
